Important signaling pathways, such as transforming growth factor β (TGF-β) and mammalian target of rapamycin (mTOR), that were downregulated in CDH samples were upregulated in the TO-treated ones. This evidence concerns the gene MTOR and congenital diaphragmatic hernia.